Lexapro clinical trials
Lexapro is named as an intervention in 3 current clinical trials in our China and Canada registers. 2 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is First Affiliated Hospital of Zhejiang University (1). The most-studied condition is Major Depressive Disorder.
Where Lexapro is approved
All regulators →Of the three regulators tracked here, the first to approve Lexapro was the US, on 14 Aug 2002. It is approved in 2 of the 3 regulators tracked here.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Lexapro
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
Patient leaflets for Lexapro
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Lexapro
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Chinese Longitudinal and Systematic Study of Bioplar Disorder
NCT05480150 · ClinicalTrials.gov ↗ · Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic
|
Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | China |
|
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD), Depression - Major Depressive Disorder
|
Not applicable | Recruiting | Gang Wang | China |
|
Escitalopram for Agitation in Alzheimer's Disease
NCT03108846 · ClinicalTrials.gov ↗ · Dementia
|
Phase 3 | Active, closed | JHSPH Center for Clinical Trials | Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Lexapro
6 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 1 |
| Gang Wang | 1 |
| JHSPH Center for Clinical Trials | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 2 |
| Clinical trials in Canada | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Lexapro trials
How many clinical trials are testing Lexapro?
3 current trials in our China and Canada registers name Lexapro as a drug or biological intervention, as of the registry sync on 16 October 2026. Completed and withdrawn studies are not counted.
Are Lexapro trials recruiting patients?
Yes. 2 of the 3 trials are recruiting: 2 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Lexapro clinical trials?
First Affiliated Hospital of Zhejiang University (1), Gang Wang (1) and JHSPH Center for Clinical Trials (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Lexapro works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Lexapro works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Lexapro (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 16 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.